Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Return on Capital Employed (2020 - 2025)

Foghorn Therapeutics (FHTX) has 5 years of Return on Capital Employed data on record, last reported at 0.45% in Q4 2024.

  • For Q4 2024, Return on Capital Employed changed 0.0% year-over-year to 0.45%; the TTM value through Dec 2024 reached 0.45%, changed 0.0%, while the annual FY2024 figure was 0.47%, 10.0% down from the prior year.
  • Return on Capital Employed reached 0.45% in Q4 2024 per FHTX's latest filing, down from 0.4% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.23% in Q1 2022 and bottomed at 0.52% in Q3 2021.
  • Average Return on Capital Employed over 5 years is 0.38%, with a median of 0.4% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: grew 23bps in 2022, then fell -16bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.38% in 2020, then grew by 13bps to 0.33% in 2021, then grew by 3bps to 0.32% in 2022, then plummeted by -39bps to 0.45% in 2023, then dropped by 0bps to 0.45% in 2024.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.45% in Q4 2024, 0.4% in Q3 2024, and 0.4% in Q2 2024.